New prostate MRI pathway to let trained radiographers make MRI decisions with computer support

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project aims to capture radiologist decision knowledge and use it to support radiographers at two UK hospitals so they can make on-the-spot prostate MRI decisions. The team will use retrospective data from about 800 patients at each site and require experienced prostate MRI radiographers who complete study-specific online and hands-on training. The program pairs the trained radiographers with a computerized decision-support pathway to determine whether routine gadolinium contrast injections and repeat imaging appointments can be reduced. Outcomes focus on feasibility, adherence to decision rules, and potential to streamline imaging workflows.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* MRI radiographers in University Hospitals of North Midlands (UHNM) and or University Hospitals of Derby and Burton (UHDB) with over 5 years' experience in MRI of the prostate.
* Radiographers from UHNM or UHDB who have completed an online and hands on study specific training materials before the testing phase.
* Retrospective data of 800 patients each from UHNM and UHDB who have had mpMRI and went on to have a biopsy.

Exclusion Criteria:

* Non-MRI radiographers.
* Radiographers who did not completed an online and hands on study specific training materials before the testing phase.
* Non-mpMRI.

Where it's running

• University Hospitals of North Midlands NHS Trust
  Stoke-on-Trent, Staffordshire, United Kingdom Recruiting

Study contacts

• Study coordinator: Aviva Ogbolosingha
• Email: aviva.ogbolosingha@uhnm.nhs.uk
• Phone: 01782 675380

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Laser therapy for prostate cancer treatment

  This study is testing a new laser treatment for men aged 50 to 80 with low to intermediate risk prostate cancer to see if it is a safer and less invasive option than traditional surgery or radiation.

  Recruiting Urological Research Network, LLC · Hialeah, Florida · NCT05698576

• Using MRI scans to monitor cancer treatment response during radiation therapy

  This study is testing if regular MRI scans can help doctors see how well radiation therapy is working for patients with advanced cancers like glioblastoma and esophageal cancer.

  Recruiting at 2 sites Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT04188535

• Targeted alpha therapy for B7-H3 expressing solid tumors using AKY-2519

  This phase 1b trial tests a radiolabeled drug (AKY-2519) to see if it's safe and tolerable in adults with B7-H3 positive advanced solid tumors, including NSCLC and SCLC, with imaging to help guide use.

  Recruiting at 2 sites Phase 1 Aktis Oncology, Inc. · Miami, Florida and 1 other locations · NCT07887971

• PSMA-guided surgery and tissue-resident T cells in node-positive prostate cancer

  This study tests whether PSMA-guided surgery can help identify and study tissue-resident T cells in prostate cancer that has spread to lymph nodes.

  Recruiting Niguarda Hospital · Milan, Lombardy · NCT07879820

• Predictive factors for response to Lu-177 PSMA therapy in metastatic castration-resistant prostate cancer

  This study tests whether imaging, dose measurements, and blood tests can predict which men with metastatic castration-resistant prostate cancer will respond to Lu-177 PSMA therapy.

  Recruiting Lithuanian University of Health Sciences · Kaunas · NCT07863986

• Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer

  This observational study tests whether salvage HDR brachytherapy can help men with locally recurrent prostate cancer after initial radiotherapy, using advanced imaging and biopsy to guide treatment.

  Recruiting at 8 sites Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic · Benidorm, Alicante and 9 other locations · NCT07860528

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.